67 related articles for article (PubMed ID: 3091691)
21. Cellular and molecular basis of human gamma delta T cell activation. Role of accessory molecules in alloactivation.
Takamizawa M; Fagnoni F; Mehta-Damani A; Rivas A; Engleman EG
J Clin Invest; 1995 Jan; 95(1):296-303. PubMed ID: 7814628
[TBL] [Abstract][Full Text] [Related]
22. Ligation of the CD5 or CD28 molecules on resting human T cells induces expression of the early activation antigen CD69 by a calcium- and tyrosine kinase-dependent mechanism.
Vandenberghe P; Verwilghen J; Van Vaeck F; Ceuppens JL
Immunology; 1993 Feb; 78(2):210-7. PubMed ID: 7682535
[TBL] [Abstract][Full Text] [Related]
23. Characterization of monoclonal antibodies specific for equine homologues of CD3 and CD5.
Blanchard-Channell M; Moore PF; Stott JL
Immunology; 1994 Aug; 82(4):548-54. PubMed ID: 7530685
[TBL] [Abstract][Full Text] [Related]
24. Anti-CD5 therapy decreases severity of established disease in collagen type II-induced arthritis in DBA/1 mice.
Plater-Zyberk C; Taylor PC; Blaylock MG; Maini RN
Clin Exp Immunol; 1994 Dec; 98(3):442-7. PubMed ID: 7527741
[TBL] [Abstract][Full Text] [Related]
25. Evidence for a trans-acting activator function regulating the expression of the human CD5 antigen.
Scupoli MT; Sartoris S; Nicolis M; Cestari T; Cambiaggi C; Tridente G; Accolla RS
Immunogenetics; 1994; 40(3):217-21. PubMed ID: 7518803
[TBL] [Abstract][Full Text] [Related]
26. The T-cell antigen CD5 acts as a receptor and substrate for the protein-tyrosine kinase p56lck.
Raab M; Yamamoto M; Rudd CE
Mol Cell Biol; 1994 May; 14(5):2862-70. PubMed ID: 7513045
[TBL] [Abstract][Full Text] [Related]
27. Expression and function of CD5 and CD28 in patients with rheumatoid arthritis.
Verwilghen J; Corrigall V; Pope RM; Rodrigues R; Panayi GS
Immunology; 1993 Sep; 80(1):96-102. PubMed ID: 7503950
[TBL] [Abstract][Full Text] [Related]
28. Surface proteins and glycoproteins of human leucocytes.
Horejsí V; Bazil V
Biochem J; 1988 Jul; 253(1):1-26. PubMed ID: 3048251
[No Abstract] [Full Text] [Related]
29. Monoclonal antibodies which react with bovine T-lymphocyte antigens and induce blastogenesis: tissue distribution and functional characteristics of the target antigens.
Baldwin CL; Machugh ND; Ellis JA; Naessens J; Newson J; Morrison WI
Immunology; 1988 Mar; 63(3):439-46. PubMed ID: 2965099
[TBL] [Abstract][Full Text] [Related]
30. T cell blast stimulation of MLR: role of interleukin 1 and interleukin 2.
Aaron S
Clin Exp Immunol; 1988 Jan; 71(1):171-6. PubMed ID: 2964955
[TBL] [Abstract][Full Text] [Related]
31. Expression of T-cell receptors TcR1 (gamma/delta) and TcR2 (alpha/beta) in the human intestinal mucosa.
Trejdosiewicz LK; Smart CJ; Oakes DJ; Howdle PD; Malizia G; Campana D; Boylston AW
Immunology; 1989 Sep; 68(1):7-12. PubMed ID: 2530157
[TBL] [Abstract][Full Text] [Related]
32. Impaired T-cell activation in patients with systemic lupus erythematosus.
Sierakowski S; Kucharz EJ; Lightfoot RW; Goodwin JS
J Clin Immunol; 1989 Nov; 9(6):469-76. PubMed ID: 2517125
[TBL] [Abstract][Full Text] [Related]
33. Phenotypic and functional characterization of human cytolytic T cells lacking expression of CD5.
Bierer BE; Nishimura Y; Burakoff SJ; Smith BR
J Clin Invest; 1988 May; 81(5):1390-7. PubMed ID: 2452832
[TBL] [Abstract][Full Text] [Related]
34. Respective contribution of intracellular calcium release and extracellular calcium influx for interleukin-2 synthesis in activated T-cell hybrids.
Williams DB; Perera MA; Dorrington KJ; Klein MH
Immunology; 1990 Mar; 69(3):468-75. PubMed ID: 2312169
[TBL] [Abstract][Full Text] [Related]
35. Basis for defective proliferation of peripheral blood T cells to anti-CD2 antibodies in primary Sjögren's syndrome.
Gerli R; Bertotto A; Agea E; Lanfrancone L; Cernetti C; Spinozzi F; Rambotti P
J Clin Invest; 1990 Dec; 86(6):1870-7. PubMed ID: 1979333
[TBL] [Abstract][Full Text] [Related]
36. Differences in the stimulating capacity of immobilized anti-CD3 monoclonal antibodies: variable dependence on interleukin-1 as a helper signal for T-cell activation.
Verwilghen J; Baroja ML; Van Vaeck F; Van Damme J; Ceuppens JL
Immunology; 1991 Feb; 72(2):269-76. PubMed ID: 1826671
[TBL] [Abstract][Full Text] [Related]
37. Protein kinase C-dependent up-regulation of CD5 surface expression on normal and lymphoblastoid T cells.
Lozano F; Alberola-Ila J; Places L; Gallart T; Vives J
Immunology; 1990 Aug; 70(4):434-9. PubMed ID: 1697562
[TBL] [Abstract][Full Text] [Related]
38. Characterization of normal human CD3+ CD5- and gamma delta T cell receptor positive T lymphocytes.
Spour EF; Leemhuis T; Jenski L; Redmond R; Fillak D; Jansen J
Clin Exp Immunol; 1990 Apr; 80(1):114-21. PubMed ID: 1691061
[TBL] [Abstract][Full Text] [Related]
39. Stimulation of CD5 enhances signal transduction by the T cell antigen receptor.
Imboden JB; June CH; McCutcheon MA; Ledbetter JA
J Clin Invest; 1990 Jan; 85(1):130-4. PubMed ID: 1688565
[TBL] [Abstract][Full Text] [Related]
40. Homotypic aggregation of murine T lymphocytes induced by anti-Thy-1 monoclonal antibodies.
Isobe K; Nakashima I
Immunology; 1991 Jun; 73(2):159-64. PubMed ID: 1676986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
